Matches in Nanopublications for { ?s ?p "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 16 of
16
with 100 items per page.
- NP640498.RAeEFlXZy8WKdIQKVlwtaPvz22x6cV5LoBql8sGCmlhI4130_assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP640498.RAeEFlXZy8WKdIQKVlwtaPvz22x6cV5LoBql8sGCmlhI4130_provenance.
- NP817229.RAvtxE4PvUPoY9FS807HOz_SqxHydSGREEXfC7Ds9fa38130_assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817229.RAvtxE4PvUPoY9FS807HOz_SqxHydSGREEXfC7Ds9fa38130_provenance.
- NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878356.RA_DLj054Os8Bg4Wx5oA7Qw6jJVwLRAm7g5OfFBV4GxGU130_provenance.
- NP643090.RASz_vH1agqolAw9ao0qd8gVtFPB6iEk09Lmo5Nx3fWeM130_assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643090.RASz_vH1agqolAw9ao0qd8gVtFPB6iEk09Lmo5Nx3fWeM130_provenance.
- NP956112.RAWUuDIRPs-0BNoq7haovqC-RWxnWCW1mlwpnKAEi7vuk130_assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP956112.RAWUuDIRPs-0BNoq7haovqC-RWxnWCW1mlwpnKAEi7vuk130_provenance.
- assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP379398.RAcrDINW5fizYIEbn26jVDbrY464CxcCTvGVdA_3N6pZg130_assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379398.RAcrDINW5fizYIEbn26jVDbrY464CxcCTvGVdA_3N6pZg130_provenance.
- NP379403.RAcnPrTEI9D7eA3p3TmrLu0r9YQcvSD1EW4OwRIjYfIyo130_assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379403.RAcnPrTEI9D7eA3p3TmrLu0r9YQcvSD1EW4OwRIjYfIyo130_provenance.
- NP379407.RAv9vZm3-8qN6z8evJmVZTvKL-zcUza9HI-1h7xwuPxZU130_assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379407.RAv9vZm3-8qN6z8evJmVZTvKL-zcUza9HI-1h7xwuPxZU130_provenance.
- NP850596.RAMfN1SNCDYq7sllr2A4zHr1EyYmphRT45sbi4UF2ZQ_k130_assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850596.RAMfN1SNCDYq7sllr2A4zHr1EyYmphRT45sbi4UF2ZQ_k130_provenance.
- NP956118.RAnNMsrmxocMDT32WAWLeitpUn2MxYVdhi7ZSqTUCbqwk130_assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP956118.RAnNMsrmxocMDT32WAWLeitpUn2MxYVdhi7ZSqTUCbqwk130_provenance.
- NP643075.RAMw8QoaqYwB1fxuJgyFfg7BYU3RTFrhpogctdrs6WRQQ130_assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643075.RAMw8QoaqYwB1fxuJgyFfg7BYU3RTFrhpogctdrs6WRQQ130_provenance.
- NP379400.RAFHjb2T7bPyLphX4DDuR5x8FfJlb02kedcVDS-pC5V6s130_assertion description "[Moreover, PRK1 activates AR even in the presence of the AR antagonist cyproterone acetate that is used in the clinical management of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379400.RAFHjb2T7bPyLphX4DDuR5x8FfJlb02kedcVDS-pC5V6s130_provenance.